Phase I and Pharmacologic Trial of Cytosine Arabinoside with the Selective Checkpoint 1 Inhibitor Sch 900776 in Refractory Acute Leukemias

PURPOSE: Incorporation of cytarabine into DNA activates checkpoint kinase 1 (Chk1), which stabilizes stalled replication forks, induces S-phase slowing, and diminishes cytarabine cytotoxicity. The selective Chk1 inhibitor SCH 900776 abrogates cytarabine-induced S-phase arrest and enhances cytarabine...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Karp, Judith E., Thomas, Brian M., Greer, Jacqueline M., Sorge, Christopher, Gore, Steven D., Pratz, Keith W., Smith, B. Douglas, Flatten, Karen S., Peterson, Kevin, Schneider, Paula, Mackey, Karen, Freshwater, Tomoko, Levis, Mark J., McDevitt, Michael A., Carraway, Hetty E., Gladstone, Douglas E., Showel, Margaret M., Loechner, Sabine, Parry, David A., Horowitz, Jo Ann, Isaacs, Randi, Kaufmann, Scott H.
Format: Artigo
Sprog:Inglês
Udgivet: 2012
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3596113/
https://ncbi.nlm.nih.gov/pubmed/23092873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-12-2442
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker